NIH-funded research R21 grant

Creating a single injection vaccine for rabies prevention after exposure

Official title: Leveraging Controlled Release to Create a Single-Injection Post-Exposure Prophylactic for Rabies

Funded at Rice University · NIH-11094018 · Data updated 2026-11-12

This study is working on a new rabies vaccine that only needs one shot instead of several, making it easier for people, especially in rural areas, to get the protection they need after being exposed to rabies.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionRice University
NIH-funded
Lab location1 site (Houston, United States)
Project startMay 23, 2024
Project endMarch 31, 2026
Funding year2025
Award (this year)$232,765
NIH project number5R21AI183245-02
Project IDNIH-11094018 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have been exposed to the rabies virus and require post-exposure prophylaxis.

Less likely to help

Patients who have already received the traditional multi-dose rabies vaccination may not benefit from this new single-injection approach.

What this research studies

This research aims to develop a single-injection rabies vaccine that can be used as post-exposure prophylaxis (PEP) to prevent rabies infection. Currently, rabies PEP requires multiple doses, which can be a barrier to access, especially in low- and middle-income countries. By utilizing an innovative drug encapsulation technique called PULSED, the researchers hope to create a more accessible and effective vaccination option. This could significantly improve survival rates for individuals exposed to the rabies virus, particularly in rural areas with limited healthcare resources.

Why it matters

Potential benefit: If successful, this research could drastically reduce rabies-related deaths by making post-exposure vaccination more accessible and easier to administer.

How similar studies have gone: While there have been efforts to reduce the number of doses in rabies vaccination, this approach of a single-injection PEP is novel and has not been extensively tested.

Where this research is happening

  • Rice University
    Houston, United States
    Active

Researchers

  • Principal investigator: Mchugh, Kevin James — Rice University
  • Study coordinator: Mchugh, Kevin James

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.